George Farmer
Stock Analyst at Scotiabank
(2.78)
# 2,972
Out of 4,829 analysts
74
Total ratings
33.33%
Success rate
0.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACLX Arcellx | Maintains: Sector Outperform | $133 → $93 | $59.50 | +56.30% | 2 | May 9, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $10.99 | +54.69% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $3.27 | +266.97% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $6.87 | +31.00% | 4 | Apr 10, 2025 | |
| ADAP Adaptimmune Therapeutics | Maintains: Sector Outperform | $3.15 → $1.4 | $0.30 | +374.25% | 2 | Mar 21, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $26.06 | +57.33% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $19.22 | +170.55% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $61.37 | +30.36% | 8 | Feb 20, 2025 | |
| BIIB Biogen | Maintains: Sector Outperform | $244 → $224 | $124.40 | +80.06% | 3 | Feb 13, 2025 | |
| VKTX Viking Therapeutics | Initiates: Sector Outperform | $102 | $28.30 | +260.42% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $14 → $12 | $6.75 | +77.78% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $22 → $23 | $7.64 | +201.05% | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $6.09 | +64.34% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $560.90 | +27.47% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $5.35 | +330.31% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $2.05 | +875.61% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $21 → $41 | $1.77 | +2,216.38% | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $32.38 | +134.71% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $2.93 | +343.69% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $25.70 | +324.12% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $60.85 | +42.97% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $1.58 | +1,988.61% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.99 | +3,953.92% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $36.98 | -26.99% | 3 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $75 | $100.27 | -25.20% | 3 | Apr 29, 2020 |
Arcellx
May 9, 2025
Maintains: Sector Outperform
Price Target: $133 → $93
Current: $59.50
Upside: +56.30%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $10.99
Upside: +54.69%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $3.27
Upside: +266.97%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $6.87
Upside: +31.00%
Adaptimmune Therapeutics
Mar 21, 2025
Maintains: Sector Outperform
Price Target: $3.15 → $1.4
Current: $0.30
Upside: +374.25%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $26.06
Upside: +57.33%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $19.22
Upside: +170.55%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $61.37
Upside: +30.36%
Biogen
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $124.40
Upside: +80.06%
Viking Therapeutics
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $28.30
Upside: +260.42%
Feb 12, 2025
Maintains: Sector Outperform
Price Target: $14 → $12
Current: $6.75
Upside: +77.78%
Feb 11, 2025
Maintains: Sector Outperform
Price Target: $22 → $23
Current: $7.64
Upside: +201.05%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $6.09
Upside: +64.34%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $560.90
Upside: +27.47%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $5.35
Upside: +330.31%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $2.05
Upside: +875.61%
Sep 27, 2024
Maintains: Sector Outperform
Price Target: $21 → $41
Current: $1.77
Upside: +2,216.38%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $32.38
Upside: +134.71%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $2.93
Upside: +343.69%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $25.70
Upside: +324.12%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $60.85
Upside: +42.97%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $1.58
Upside: +1,988.61%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.99
Upside: +3,953.92%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $36.98
Upside: -26.99%
Apr 29, 2020
Maintains: Outperform
Price Target: $89 → $75
Current: $100.27
Upside: -25.20%